TFA
OM icon

Transamerica Financial Advisors’s Outset Medical OM Stock Holding History

Transamerica Financial Advisors’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$108 Buy
25
+11
+79% +$48 ﹤0.01% 1990
2026
Q1 		$53 Sell
14
-2
-13% -$8 ﹤0.01% 1873
2025
Q4 		$59 Buy
+16
New +$137 ﹤0.01% 1760

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Transamerica Financial Advisors's OM Position: Q2 2026 in Review

Transamerica Financial Advisors increased its Outset Medical (OM) stake by 79% in Q2 2026, buying an estimated $48 and bringing the position to 25 shares worth $108. The position accounts for ﹤0.01% of the portfolio, ranked #1990.

Transamerica Financial Advisors first reported a position in OM in Q4 2025 and has held it in 3 quarters since. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Transamerica Financial Advisors held 25 shares of Outset Medical worth $108 as of Q2 2026.
  • Transamerica Financial Advisors bought 11 Outset Medical shares in Q2 2026, an estimated $48.
  • Outset Medical made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1990 holding.
  • Transamerica Financial Advisors first reported a position in Outset Medical in Q4 2025 and has held it in 3 quarters since.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.